PH21561A - Pharmaceutical compositions containing 3-hydroxy- butanoic acid or salt derived from this acid and compounds derived from 3-hydroxy butanoic acid which can be used as medicaments - Google Patents

Pharmaceutical compositions containing 3-hydroxy- butanoic acid or salt derived from this acid and compounds derived from 3-hydroxy butanoic acid which can be used as medicaments

Info

Publication number: PH21561A
Authority: PH; Philippines
Prior art keywords: hydroxy; acid; butanoic acid; derived; pharmaceutical compositions
Prior art date: 1982-02-23

Application number

PH28545A

Other languages

English (en)

Inventor

Lammerant Jacques

Kolanowski Jaroslaw

Original Assignee

Solvay

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1982-02-23

Filing date

1983-02-21

Publication date

1987-12-11

1983-02-21 Application filed by Solvay filed Critical Solvay

1987-12-11 Publication of PH21561A publication Critical patent/PH21561A/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/01—Saturated compounds having only one carboxyl group and containing hydroxy or O-metal groups

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

PH28545A 1982-02-23 1983-02-21 Pharmaceutical compositions containing 3-hydroxy- butanoic acid or salt derived from this acid and compounds derived from 3-hydroxy butanoic acid which can be used as medicaments PH21561A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR8203100A FR2521857B1 (fr)	1982-02-23	1982-02-23	Compositions pharmaceutiques contenant de l'acide 3-hydroxybutanoique ou un sel derive de cet acide et sels derives de l'acide 3-hydroxybutanoique et d'une base organique azotee

Publications (1)

Publication Number	Publication Date
PH21561A true PH21561A (en)	1987-12-11

Family

ID=9271331

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PH28545A PH21561A (en)	1982-02-23	1983-02-21	Pharmaceutical compositions containing 3-hydroxy- butanoic acid or salt derived from this acid and compounds derived from 3-hydroxy butanoic acid which can be used as medicaments

Country Status (21)

Country	Link
US (2)	US4579955A (da)
EP (1)	EP0087192B1 (da)
JP (1)	JPS58201746A (da)
KR (1)	KR910000143B1 (da)
AT (1)	ATE24478T1 (da)
AU (2)	AU560757B2 (da)
CA (1)	CA1203242A (da)
DE (1)	DE3368601D1 (da)
DK (1)	DK163235C (da)
ES (2)	ES519991A0 (da)
FI (1)	FI79523C (da)
FR (1)	FR2521857B1 (da)
GR (1)	GR77934B (da)
IE (1)	IE54561B1 (da)
IL (1)	IL67965A0 (da)
MX (1)	MX156855A (da)
NO (1)	NO161909C (da)
NZ (1)	NZ203279A (da)
PH (1)	PH21561A (da)
PT (1)	PT76267A (da)
ZA (1)	ZA831019B (da)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2521857B1 (fr) *	1982-02-23	1985-10-31	Solvay	Compositions pharmaceutiques contenant de l'acide 3-hydroxybutanoique ou un sel derive de cet acide et sels derives de l'acide 3-hydroxybutanoique et d'une base organique azotee
USRE38604E1 (en)	1984-06-22	2004-09-28	Btg International Limited	Fluid therapy with L-lactate and/or pyruvate anions
US6020007A (en) *	1984-06-22	2000-02-01	Btg International Limited	Fluid therapy with l-lactate and/or pyruvate anions
US4777288A (en) *	1987-06-11	1988-10-11	Pfizer Inc.	Process for preparing a 4,4-diphenylbutanoic acid derivative
BE1001209A3 (fr) *	1987-11-19	1989-08-22	Solvay	Compositions pharmaceutiques contenant un derive de l'acide 3-hydroxybutanoique choisi parmi les oligomeres de cet acide et les esters de cet acide ou de ces oligomeres avec du 1,3-butanediol.
US5292774A (en) *	1988-07-26	1994-03-08	Kanegafuchi Kagaku Kogyo Kabushiki Kaisha	Substitution fluid preparation comprising 3-hydroxy-butyric acid (β-hydroxybutric acid) and its salts
DE4113984C2 (de) *	1991-04-29	2002-05-08	Koehler Chemie Dr Franz	Salze der 4-Hydroxy-Buttersäure
ES2051222B1 (es) *	1992-03-12	1995-02-16	Sanmiguel Gabriel Serrano	Procedimiento de neutralizacion de acido alfa-hidroxietanoico.
JP4598203B2 (ja) *	1995-12-01	2010-12-15	ビーティージー・インターナショナル・リミテッド	脳機能改善剤
US6316038B1 (en)	1997-03-17	2001-11-13	Btg International Limited	Therapeutic compositions
US6323237B1 (en)	1997-03-17	2001-11-27	Btg International Limited	Therapeutic compositions
DK1017379T3 (da) *	1997-03-17	2015-02-16	Btg Int Ltd	Terapeutiske sammensætninger omfattende ketonforbindelser og forstadier deraf
US20090253781A1 (en) *	2002-05-24	2009-10-08	Btg International Limited	Therapeutic compositions
US6613356B1 (en)	2000-10-10	2003-09-02	Victor Vlahakos	Weight loss medication and method
GB0420856D0 (en) *	2004-09-20	2004-10-20	Ketocytonyx Inc	Cns modulators
WO2006020137A2 (en) *	2004-07-16	2006-02-23	Ketocytonyx Inc.	Oligomeric compounds
WO2006020179A2 (en) *	2004-07-20	2006-02-23	Ketocytonyx Inc.	Oligomeric ketone compounds
US20070225252A1 (en) *	2004-07-23	2007-09-27	Gross Richard A	Ketogenic Saccharides
WO2006098767A2 (en) *	2004-09-21	2006-09-21	Ketocytonyx Inc.	Treatment of adhd
ES2574557T3 (es) *	2004-09-21	2016-06-20	Btg International Limited	Miméticos dopaminérgicos
WO2008053982A1 (fr)	2006-10-30	2008-05-08	Ophtecs Corporation	Composition pour le traitement de l'allergie
EP2914251B1 (en)	2012-11-05	2019-08-21	The United States of America, as represented by The Secretary, Department of Health and Human Services	Ketone bodies to protect tissues from damage by ionizing radiation
TWI716495B (zh)	2015-11-19	2021-01-21	日商協和發酵生化股份有限公司	3-羥基異戊酸之一價陽離子鹽之結晶及該結晶之製造方法
US11241403B2 (en)	2016-03-11	2022-02-08	Axcess Global Sciences, Llc	Beta-hydroxybutyrate mixed salt compositions and methods of use
US11103470B2 (en)	2017-11-22	2021-08-31	Axcess Global Sciences, Llc	Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the R-enantiomer and methods of use
US11806324B2 (en)	2018-04-18	2023-11-07	Axcess Global Sciences, Llc	Beta-hydroxybutyric acid compositions and methods for oral delivery of ketone bodies
US10925843B2 (en)	2018-04-18	2021-02-23	Axcess Global Sciences, Llc	Compositions and methods for keto stacking with beta-hydroxybutyrate and acetoacetate
US12109182B2 (en)	2016-04-19	2024-10-08	Axcess Global Sciences, Llc	Administration of R-beta-hydroxybutyrate and related compounds in humans
JP6710098B2 (ja) *	2016-05-10	2020-06-17	大阪瓦斯株式会社	栄養剤組成物及び栄養補助食品
US11098007B2 (en)	2016-06-24	2021-08-24	Kyowa Hakko Bio Co., Ltd.	Crystal of amino acid salt of 3-hydroxyisovaleric acid and production method thereof
US12090129B2 (en)	2017-11-22	2024-09-17	Axcess Global Sciences, Llc	Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the R-enantiomer and methods of use
US11202769B2 (en)	2017-11-22	2021-12-21	Axcess Global Sciences, Llc	Ketone body esters of s-beta-hydroxybutyrate and/or s-1,3-butanediol for modifying metabolic function
US11944598B2 (en)	2017-12-19	2024-04-02	Axcess Global Sciences, Llc	Compositions containing s-beta-hydroxybutyrate or non-racemic mixtures enriched with the s-enatiomer
US12167993B2 (en)	2019-06-21	2024-12-17	Axcess Global Sciences, Llc	Non-vasoconstricting energy-promoting compositions containing ketone bodies
US11969430B1 (en)	2023-03-10	2024-04-30	Axcess Global Sciences, Llc	Compositions containing paraxanthine and beta-hydroxybutyrate or precursor for increasing neurological and physiological performance
US11950616B2 (en)	2019-06-21	2024-04-09	Axcess Global Sciences, Llc	Non-vasoconstricting energy-promoting compositions containing ketone bodies
CN112341331B (zh) *	2019-08-07	2023-04-07	辽宁科硕营养科技股份有限公司	一种3-羟基丁酸盐及其制备方法与应用
US12186297B2 (en)	2020-08-26	2025-01-07	Axcess Global Sciences, Llc	Compositions and methods for increasing lean-to-fat mass ratio
WO2024192165A1 (en) *	2023-03-14	2024-09-19	The Board Of Trustees Of The Leland Stanford Junior University	N-beta-hydroxybutyryl-amino acids and related compositions and methods

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2101097A (en) *	1934-07-26	1937-12-07	Wm S Merrell Co	Products for rendering the urine bacteriostatic
US2799684A (en) *	1954-06-18	1957-07-16	Food Chemical And Res Lab Inc	Crystalline compounds of tryptophane and methods of manufacturing them
NL279760A (da) *	1961-06-17
US3830931A (en) *	1972-11-06	1974-08-20	Felice S De	Carnitine and its use in the treatment of arrhythmia and impaired cardiac function
US3879537A (en) *	1973-09-04	1975-04-22	Scott Eugene J Van	Treatment of ichthyosiform dermatoses
DE2733202A1 (de) *	1976-08-04	1978-02-09	Agroferm Ag	Verfahren zur herstellung der d(-)-3-hydroxybuttersaeure
US4412943A (en) *	1981-02-23	1983-11-01	Kao Soap Co., Ltd.	Liquid detergent composition
FR2521857B1 (fr) *	1982-02-23	1985-10-31	Solvay	Compositions pharmaceutiques contenant de l'acide 3-hydroxybutanoique ou un sel derive de cet acide et sels derives de l'acide 3-hydroxybutanoique et d'une base organique azotee

1982
- 1982-02-23 FR FR8203100A patent/FR2521857B1/fr not_active Expired
1983
- 1983-02-15 ZA ZA831019A patent/ZA831019B/xx unknown
- 1983-02-15 DE DE8383200228T patent/DE3368601D1/de not_active Expired
- 1983-02-15 EP EP83200228A patent/EP0087192B1/fr not_active Expired
- 1983-02-15 AT AT83200228T patent/ATE24478T1/de active
- 1983-02-15 NZ NZ203279A patent/NZ203279A/en unknown
- 1983-02-17 AU AU11624/83A patent/AU560757B2/en not_active Ceased
- 1983-02-21 IL IL67965A patent/IL67965A0/xx not_active IP Right Cessation
- 1983-02-21 GR GR70556A patent/GR77934B/el unknown
- 1983-02-21 PT PT76267A patent/PT76267A/pt not_active IP Right Cessation
- 1983-02-21 PH PH28545A patent/PH21561A/en unknown
- 1983-02-22 ES ES519991A patent/ES519991A0/es active Granted
- 1983-02-22 NO NO830618A patent/NO161909C/no unknown
- 1983-02-22 MX MX196357A patent/MX156855A/es unknown
- 1983-02-22 US US06/468,385 patent/US4579955A/en not_active Expired - Fee Related
- 1983-02-22 IE IE366/83A patent/IE54561B1/en not_active IP Right Cessation
- 1983-02-23 KR KR1019830000728A patent/KR910000143B1/ko not_active IP Right Cessation
- 1983-02-23 DK DK081583A patent/DK163235C/da not_active IP Right Cessation
- 1983-02-23 FI FI830603A patent/FI79523C/fi not_active IP Right Cessation
- 1983-02-23 CA CA000422215A patent/CA1203242A/fr not_active Expired
- 1983-02-23 JP JP58029197A patent/JPS58201746A/ja active Pending
1984
- 1984-05-28 ES ES532880A patent/ES532880A0/es active Granted
1985
- 1985-10-23 US US06/790,391 patent/US4771074A/en not_active Expired - Fee Related
1987
- 1987-02-23 AU AU69161/87A patent/AU602329B2/en not_active Ceased

Also Published As

Publication number	Publication date
ES8500240A1 (es)	1984-10-01
MX156855A (es)	1988-10-07
FI830603L (fi)	1983-08-24
EP0087192A1 (fr)	1983-08-31
JPS58201746A (ja)	1983-11-24
US4771074A (en)	1988-09-13
DE3368601D1 (en)	1987-02-05
ZA831019B (en)	1983-11-30
NZ203279A (en)	1985-04-30
FI79523B (fi)	1989-09-29
AU602329B2 (en)	1990-10-11
ES8506283A1 (es)	1985-07-01
US4579955A (en)	1986-04-01
FR2521857B1 (fr)	1985-10-31
FR2521857A1 (fr)	1983-08-26
ATE24478T1 (de)	1987-01-15
ES532880A0 (es)	1985-07-01
DK163235C (da)	1992-06-29
AU1162483A (en)	1983-09-01
PT76267A (fr)	1983-03-01
DK163235B (da)	1992-02-10
IE54561B1 (en)	1989-11-22
NO161909C (no)	1989-10-11
FI830603A0 (fi)	1983-02-23
GR77934B (da)	1984-09-25
DK81583A (da)	1983-08-24
AU560757B2 (en)	1987-04-16
EP0087192B1 (fr)	1986-12-30
KR910000143B1 (ko)	1991-01-21
FI79523C (fi)	1990-01-10
IE830366L (en)	1983-08-23
AU6916187A (en)	1987-05-21
IL67965A0 (en)	1983-06-15
NO161909B (no)	1989-07-03
NO830618L (no)	1983-08-24
KR840003414A (ko)	1984-09-08
DK81583D0 (da)	1983-02-23
CA1203242A (fr)	1986-04-15
ES519991A0 (es)	1984-10-01

Publication	Publication Date	Title
PH21561A (en)	1987-12-11	Pharmaceutical compositions containing 3-hydroxy- butanoic acid or salt derived from this acid and compounds derived from 3-hydroxy butanoic acid which can be used as medicaments
DE3469534D1 (en)	1988-04-07	Modified proteinase inhibitors, process for their preparation and pharmaceutical compositions containing them
IL127352A (en)	2003-10-31	Pyridyl alkene- and pyridyl alkine-acid amides and pharmaceutical compositions containing them
NZ225758A (en)	1990-10-26	Substituted amine derivatives; pharmaceutical compositions and processes for preparation
AP2000001888A0 (en)	2000-09-30	Method for treatment of diabetes using peptides analogues of insulin.
IL104716A (en)	1997-09-30	7-1-oxo-2- (substituted mercapto)-3- phenylpropyl) amino\| octahydro-6-pyrido £2, 1-a\| benzazepine- 4-carboxylic acid derivatives and analogs, their preparation and pharmaceutical compositions containing them for inhibiting enkephalinase and ace
YU48666B (sh)	1999-06-15	Mometason furoat monohidrat i postupak za njegovo dobijanje
ES8609312A1 (es)	1986-09-01	Procedimiento para la preparacion de silibinina exenta de isosilibina
HUT55034A (en)	1991-04-29	Process for producing peptides with hemoregulating effect and pharmaceutical compositions comprising such compounds as active ingredient
SE9503679D0 (sv)	1995-10-20	Antioxidants
DK482185D0 (da)	1985-10-21	Peptider, deres fremstilling og anvendelse som laegemidler
PT83045B (pt)	1988-07-01	Processo para a obtencao de derivados aminoalcoois peptidicos contendo um atomo de carbono tetrasubstituido inibidores da renina e das proteases acidas
GR3004764T3 (da)	1993-04-28
PL338294A1 (en)	2000-10-23	Derivatives of streptogramins, method of obtaining them and compositions containing such derivatives
DE3466213D1 (en)	1987-10-22	Arphamenine and its related compounds, a process for their preparation and their use as medicaments
DE3162674D1 (en)	1984-04-19	A purified polypeptide, a process for its preparation, its use and pharmaceutical compositions containing it